Buscar
Mostrando ítems 1-10 de 771
Influencia de HLA-DM en la estabilidad del complejo formado entre la molécula HLA-DR4 y un péptido de la proteína CS de P. falciparum
(2011)
En este trabajo se investigó acerca de la estabilidad cinética y la susceptibilidad a la edición por la molécula HLA-DM de los complejos HLA-DR4/T*-1 y HLA-DR4/QNT-6. HLA-DR4 une el péptido T*-1 con 10 a 15 veces más ...
Expression of the classical and nonclassical HLA molecules in breast cancer
(International Journal Of Breast Cancer, 2013)
Considering that downregulation of HLA expression could represent a potential mechanism for breast carcinogenesis and metastasis, the aim of the present study was to use immunohistochemical methods to analyze the expression ...
NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ
(Springer, 2013-10)
Major histocompatibility complex class II (MHCII) molecules play an important role in cell-mediated immunity. They present specific peptides derived from endosomal proteins for recognition by T helper cells. The identification ...
Marcadores genéticos HLA e desenvolvimento de anticorpos anti-HLA em candidatos ao transplante renal da região Norte/Noroeste do Estado do ParanáGenetic markers HLA and development of anti-HLA antibodies in renal transplant candidates from North/Northwest of Parana State
(Universidade Estadual de MaringáBrasilPrograma de Pós-Graduação em Ciências da SaúdeUEMMaringá, PRCentro de Ciências da Saúde, 2018)
Immunohistochemical expression of HLA-DR in the conjunctiva of patients under topical prostaglandin analogs treatment
(2009-03-01)
PURPOSE: Subclinical inflammation may be observed in patients using topical antiglaucomatous drugs. The objective of this study was to investigate inflammation in conjunctiva of glaucoma patients using prostaglandin analogs, ...
Immunohistochemical expression of HLA-DR in the conjunctiva of patients under topical prostaglandin analogs treatment
(2009-03-01)
PURPOSE: Subclinical inflammation may be observed in patients using topical antiglaucomatous drugs. The objective of this study was to investigate inflammation in conjunctiva of glaucoma patients using prostaglandin analogs, ...